RAB5A and hepatocellular carcinoma: The results (Figure 6C) showed that patients with high Rab5 expression exhibited poorer overall survival compared to those with low expression in liver hepatocellular carcinoma (LIHC), indicating that Rab5 overexpression is a negative prognostic biomarker in HCC and underscoring the prognostic potential of Rab5 isoforms in HCC55,56.